Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen

Tumor-infiltrating lymphocyte (TIL) therapy has shown promising results against several cancers. However, traditional lymphodepleting regimens are severe and represent a major limitation for a more widespread use of TIL. The modified pretreatment strategies may alleviate side effects and demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jing, Luo, Ning, Ai, Guihai, Yang, Weihong, Zhu, Jihui, Li, Caixia, Chen, Rong, Zhang, Changbao, Liu, Shupeng, Jin, Huajun, Cheng, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860082/
https://www.ncbi.nlm.nih.gov/pubmed/35177415
http://dx.doi.org/10.1136/jitc-2021-003887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860082/
https://www.ncbi.nlm.nih.gov/pubmed/35177415
http://dx.doi.org/10.1136/jitc-2021-003887

Ejemplares similares